David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PUT
Cigna
CI
$74.1B
| $22.5M | 0.02% |
112,600
+84,900
| +306% | +$18.5M |
|
|
SRNE
852
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $22.5M | 0.02% |
2,952,835
+1,142,466
| +63% | +$9.69M |
|
853
Fulcrum Therapeutics
FULC
$293M
| $22.5M | 0.02% |
+798,101
| New | +$15.1M |
|
854
Trip.com Group
TCOM
$29B
| $22.5M | 0.02% |
730,948
-1,405,681
| -66% | -$40.4M |
|
855
Cisco
CSCO
$434B
| $22.5M | 0.02% |
412,546
-2,488,839
| -86% | -$140M |
|
856
3M
MMM
$92.3B
| $22.4M | 0.02% |
152,753
-206,326
| -57% | -$33.4M |
|
857
Brookfield Renewable
BEPC
$6.1B
| $22.3M | 0.02% |
575,544
-265,916
| -32% | -$11.1M |
|
|
SBNY
858
PUT
DELISTED
Signature Bank
SBNY
| $22.1M | 0.02% |
81,300
+33,100
| +69% | +$8.31M |
|
|
NEE.PRP
859
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $22.1M | 0.02% |
433,338
-319,394
| -42% | -$16.7M |
|
860
Vermilion Energy
VET
$1.92B
| $22.1M | 0.02% |
2,240,034
-540,700
| -19% | -$3.96M |
|
|
AVB
861
CALL
DELISTED
AvalonBay Communities
AVB
| $22.1M | 0.02% |
99,700
+52,400
| +111% | +$11.8M |
|
|
CS
862
DELISTED
Credit Suisse Group
CS
| $22.1M | 0.02% |
2,238,514
-770,524
| -26% | -$7.87M |
|
863
PUT
Tencent Music
TME
$14.2B
| $22M | 0.02% |
3,036,000
+1,364,300
| +82% | +$13.4M |
|
864
PUT
Occidental Petroleum
OXY
$60.1B
| $21.9M | 0.02% |
741,300
-150,300
| -17% | -$4.01M |
|
865
Comstock Resources
CRK
$4.19B
| $21.9M | 0.02% |
2,118,599
-385,156
| -15% | -$2.61M |
|
|
AVNS
866
DELISTED
Avanos Medical
AVNS
| $21.9M | 0.02% |
702,235
+187,548
| +36% | +$6.36M |
|
867
PUT
Expedia Group
EXPE
$40.7B
| $21.9M | 0.02% |
133,600
-80,200
| -38% | -$12.4M |
|
|
QVCGA
868
DELISTED
QVC Group Inc Series A
QVCGA
| $21.9M | 0.02% |
42,972
+18,245
| +74% | +$10.3M |
|
869
CALL
Warner Bros
WBD
$72B
| $21.9M | 0.02% |
861,800
+200,900
| +30% | +$5.65M |
|
|
CONX
870
DELISTED
CONX Corp. Class A Common Stock
CONX
| $21.8M | 0.02% |
2,228,806
+210,477
| +10% | +$2.06M |
|
871
Green Dot
GDOT
$765M
| $21.8M | 0.02% |
432,341
-16,740
| -4% | -$805K |
|
872
Stratasys
SSYS
$670M
| $21.7M | 0.02% |
1,009,739
-244,448
| -19% | -$5.3M |
|
|
AIRC
873
DELISTED
Apartment Income REIT Corp.
AIRC
| $21.7M | 0.02% |
443,611
-24,704
| -5% | -$1.25M |
|
874
CALL
Roku
ROKU
$23.5B
| $21.7M | 0.02% |
69,100
-37,000
| -35% | -$13.9M |
|
875
Veeco
VECO
$2.86B
| $21.6M | 0.02% |
973,650
-2,788
| -0.3% | -$62.1K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.